Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › NJ › PHILLIPSBURG › ST. LUKE'S WARREN HOSPITAL, INC.

ST. LUKE'S WARREN HOSPITAL, INC.

NPI: 1760488266 · PHILLIPSBURG, NJ 08865 · General Acute Care Hospital · NPI assigned 06/21/2005

$38.50M
Total Medicaid Paid
656,635
Total Claims
491,786
Beneficiaries
245
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialALBERTO, CARL (VICE PRESIDENT OF FINANCE)
NPI Enumeration Date06/21/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 80,411 $4.65M
2019 82,486 $4.96M
2020 65,961 $3.59M
2021 86,100 $4.58M
2022 109,392 $6.66M
2023 124,464 $7.73M
2024 107,821 $6.33M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 25,538 23,501 $9.45M
99284 Emergency department visit for the evaluation and management, high severity 18,248 16,319 $7.30M
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 11,252 9,913 $3.86M
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple 1,415 1,351 $1.89M
41899 Unlisted procedure, dentoalveolar structures 892 821 $1.61M
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1,447 1,369 $1.54M
G0378 Hospital observation service, per hour 3,714 1,963 $1.47M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6,420 6,056 $1.39M
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination 35,250 9,497 $1.29M
97530 Therapeutic activities, direct patient contact, each 15 minutes 13,917 5,033 $677K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 13,683 4,671 $574K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 40,309 11,229 $563K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 8,585 2,297 $498K
OP250 47,067 34,619 $483K
74177 Computed tomography, abdomen and pelvis; with contrast material 5,004 4,619 $457K
93017 617 582 $364K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 5,083 3,703 $223K
97597 1,119 595 $197K
41820 95 84 $178K
77067 Screening mammography, bilateral, including computer-aided detection 2,010 1,952 $174K
45380 Colonoscopy, flexible; with biopsy, single or multiple 242 232 $162K
96361 Intravenous infusion, hydration; each additional hour 8,455 7,290 $154K
70450 Computed tomography, head or brain; without contrast material 4,172 3,801 $148K
92557 451 418 $140K
97161 2,478 2,401 $138K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 12,555 10,790 $133K
93971 303 287 $132K
80053 Comprehensive metabolic panel 26,186 21,678 $129K
92567 858 807 $107K
74176 Computed tomography, abdomen and pelvis; without contrast material 1,773 1,609 $107K
96375 Therapeutic injection; each additional sequential IV push 7,233 6,211 $106K
76830 Ultrasound, transvaginal 1,062 1,030 $101K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 9,589 8,496 $98K
97162 1,814 1,740 $91K
71045 Radiologic examination, chest; single view 8,104 7,350 $86K
71046 Radiologic examination, chest; 2 views 4,040 3,865 $85K
36415 Collection of venous blood by venipuncture 32,978 27,020 $83K
OP370 972 702 $82K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 131 116 $81K
94060 126 124 $78K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 29,002 23,517 $78K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4,379 3,712 $73K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 2,892 2,661 $70K
80320 1,385 1,275 $66K
77063 Screening digital breast tomosynthesis, bilateral 1,716 1,663 $65K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 6,304 5,671 $59K
72125 Computed tomography, cervical spine; without contrast material 1,405 1,267 $53K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 4,257 3,890 $48K
71260 Computed tomography, thorax, diagnostic; with contrast material 512 453 $48K
71275 Computed tomographic angiography, chest, with contrast material 751 694 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited 983 938 $46K
73630 2,632 2,429 $46K
73562 1,719 1,566 $45K
71250 494 429 $45K
T1015 Clinic visit/encounter, all-inclusive 951 225 $42K
73610 2,453 2,260 $41K
73030 2,057 1,897 $39K
73130 1,671 1,511 $36K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 65 64 $34K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,409 2,190 $34K
73110 1,500 1,320 $30K
80048 Basic metabolic panel (calcium, ionized) 5,577 4,699 $27K
84484 7,734 6,428 $27K
J3010 Injection, fentanyl citrate, 0.1 mg 3,733 2,793 $25K
J3490 Unclassified drugs 4,020 2,527 $25K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour 785 588 $25K
73564 1,253 1,140 $23K
97163 783 706 $22K
76642 387 376 $22K
94760 1,082 815 $22K
82948 4,606 3,384 $22K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 55 39 $21K
OP710 634 420 $21K
J2405 Injection, ondansetron hydrochloride, per 1 mg 7,218 5,445 $20K
73502 936 870 $20K
J2250 Injection, midazolam hydrochloride, per 1 mg 2,776 2,132 $19K
92526 338 117 $19K
72100 909 875 $18K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,563 4,923 $18K
83735 7,995 6,240 $16K
99281 Emergency department visit for the evaluation and management, self-limited or minor 69 65 $16K
85610 6,161 5,433 $16K
81001 9,671 8,738 $15K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 4,614 3,637 $14K
88305 Level IV - Surgical pathology, gross and microscopic examination 2,688 2,533 $14K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 56 26 $14K
84443 Thyroid stimulating hormone (TSH) 4,537 4,113 $14K
85730 5,278 4,848 $13K
85027 3,416 2,717 $13K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 28 28 $12K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) 270 261 $12K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 82 76 $12K
83690 7,149 6,332 $12K
81003 5,483 5,102 $11K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 889 827 $11K
J0690 Injection, cefazolin sodium, 500 mg 1,413 1,064 $11K
70496 109 102 $11K
87040 1,504 1,363 $11K
74018 405 351 $11K
93970 12 12 $11K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 443 426 $10K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 2,742 2,297 $10K
97535 Self-care/home management training, each 15 minutes 193 73 $10K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B 408 397 $10K
83605 1,825 1,662 $10K
94729 83 83 $10K
87631 954 944 $10K
OP270 2,782 2,534 $9K
97116 424 202 $9K
94726 82 80 $8K
83880 2,106 1,871 $8K
73140 837 747 $8K
87081 647 626 $7K
70498 105 97 $7K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) 15 15 $6K
76536 105 100 $6K
87086 Culture, bacterial; quantitative colony count, urine 3,243 2,946 $6K
81025 8,597 7,927 $6K
73560 323 298 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1,948 1,765 $6K
84702 728 580 $6K
96376 605 523 $6K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,489 2,346 $5K
97166 100 89 $5K
96367 471 279 $5K
80061 Lipid panel 2,944 2,709 $5K
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 568 492 $5K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 1,055 1,001 $5K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 1,055 1,001 $5K
92587 16 15 $5K
87186 1,265 1,163 $5K
97164 102 101 $4K
87070 1,557 1,479 $4K
J1885 Injection, ketorolac tromethamine, per 15 mg 8,494 6,113 $4K
J7050 Infusion, normal saline solution, 250 cc 1,304 723 $4K
84100 1,672 1,315 $4K
73080 186 177 $4K
82077 2,352 2,007 $4K
87077 1,100 1,015 $4K
70486 62 62 $4K
86900 1,074 820 $3K
71271 26 25 $3K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 78 74 $3K
A9585 Injection, gadobutrol, 0.1 ml 1,241 1,116 $3K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 51 51 $3K
C1769 Guide wire 63 49 $3K
G1004 Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program 1,843 1,414 $3K
A9270 Non-covered item or service 2,399 1,483 $3K
83036 Hemoglobin; glycosylated (A1C) 2,436 2,235 $3K
76770 38 37 $3K
J2704 Injection, propofol, 10 mg 6,511 4,309 $2K
97533 97 39 $2K
J7030 Infusion, normal saline solution , 1000 cc 5,021 4,338 $2K
80143 601 535 $2K
80179 550 491 $2K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 1,059 971 $2K
85379 1,857 1,741 $2K
97167 72 60 $2K
J2270 Injection, morphine sulfate, up to 10 mg 968 751 $2K
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 1,385 1,259 $2K
OP259 310 179 $2K
87430 790 784 $2K
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 1,209 1,127 $2K
86901 1,107 835 $2K
87147 331 324 $1K
88342 350 306 $1K
J1756 Injection, iron sucrose, 1 mg 48 26 $1K
J2785 Injection, regadenoson, 0.1 mg 30 25 $1K
86803 612 553 $1K
80076 189 187 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,200 942 $1K
72110 28 28 $1K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 255 250 $1K
77065 Tomosynthesis, mammo 13 13 $1K
87205 428 389 $1K
77080 30 29 $1K
84145 311 250 $997.40
82570 704 623 $950.33
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 198 198 $879.19
90715 323 314 $792.47
86780 251 205 $788.64
82550 397 334 $761.26
82728 683 629 $759.47
84439 901 824 $749.32
74022 70 66 $736.19
J1170 Injection, hydromorphone, up to 4 mg 1,721 987 $726.69
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 160 123 $721.10
85007 762 616 $715.18
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 80 79 $685.34
73590 40 39 $661.06
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 255 250 $544.01
10060 28 27 $542.80
J3475 Injection, magnesium sulfate, per 500 mg 1,189 911 $527.55
J7120 Ringers lactate infusion, up to 1000 cc 1,163 1,099 $495.21
J2765 Injection, metoclopramide hcl, up to 10 mg 1,328 1,109 $488.77
73660 12 12 $439.25
82607 487 445 $437.26
83540 695 640 $413.28
80329 105 101 $374.63
73090 13 12 $339.40
83550 608 557 $287.27
86850 428 299 $286.47
73100 14 12 $271.07
C9113 Injection, pantoprazole sodium, per vial 360 287 $267.30
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 499 413 $259.03
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 431 370 $238.39
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 386 365 $210.12
87400 145 144 $189.79
86140 605 534 $169.36
J1650 Injection, enoxaparin sodium, 10 mg 208 108 $169.34
85652 651 568 $127.81
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 57 51 $118.39
82043 260 243 $104.02
29125 12 12 $100.03
84703 194 176 $98.20
J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg 193 131 $97.73
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 107 106 $94.91
82746 120 112 $93.69
86618 67 57 $79.89
82805 54 40 $75.92
J2919 Injection, methylprednisolone sodium succinate, 5 mg 105 71 $57.72
83970 32 28 $56.59
72020 222 209 $53.56
87807 64 64 $53.18
J2060 Injection, lorazepam, 2 mg 465 350 $44.07
87340 47 33 $36.00
J1644 Injection, heparin sodium, per 1000 units 120 52 $28.96
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 419 310 $28.90
J1171 Injection, hydromorphone, 0.1 mg 36 25 $21.78
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml 920 667 $21.32
J0330 Injection, succinylcholine chloride, up to 20 mg 14 13 $18.86
J1040 Injection, methylprednisolone acetate, 80 mg 284 248 $14.59
J2003 Injection, lidocaine hydrochloride, 1 mg 178 155 $12.80
J1596 Injection, glycopyrrolate, 0.1 mg 60 31 $11.60
84156 16 13 $8.70
J2470 Injection, pantoprazole sodium, 40 mg 31 27 $2.37
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 17 13 $1.00
J1010 Injection, methylprednisolone acetate, 1 mg 75 61 $0.00
J0696 Injection, ceftriaxone sodium, per 250 mg 26 26 $0.00
G8982 Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 105 97 $0.00
G8981 Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals 47 44 $0.00
86308 15 13 $0.00
12001 14 14 $0.00
G8984 Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals 375 352 $0.00
G8985 Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 444 399 $0.00